The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1249
December 4, 2006
View Complete Issue         Table of Contents 2019 
Intravenous Immunoglobulin (IVIG)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Intravenous Immunoglobulin (IVIG)
December 4, 2006 (Issue: 1249)
Intravenous immunoglobulin (IVIG) has 6 FDA approved indications and is prescribed off-label for many others. How many of these uses are justified is controversial.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Intravenous Immunoglobulin (IVIG)
Article code: 1249c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.